Farahzad Jabbari Azad

Farahzad Jabbari Azad

Auto-generated profile, based on publicly available information

Farahzad Jabbari Azad

Allergy research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Allergology International
Verified
Journal Article
Open access
RNReihaneh Noorbakhsh
Reihaneh Noorbakhsh
SMSeyed Ali Moratazavi
Seyed Ali Moratazavi
MSMojtaba Sankian
Mojtaba Sankian
FSFakhri Shahidi
Fakhri Shahidi
MTMohsen Tehrani
Mohsen Tehrani
AVAbdolReza Varasteh
AbdolReza Varasteh
Tree nut allergy is characterized by a high frequency of life-threatening reactions and is typically lifelong persistent. Some people with a pistachio nut allergy, which is common in the pistachio rich area of Iran, develop a hypersensitivity to other tree nuts as well. The aim of this study was to investigate the prevalence of pistachio nut allergy in Iran, the major pistachio cultivation region in the world. The study also addressed the presence of allergenic cross-reactivity between pistachio and other nuts, including almond, peanut, and cashew in pistachio allergic patients. A survey was conducted to determine whether the prevalence of pistachio allergy is affected by exposure to this nut in pistachio cultivation regions, as well as possible cross-reactivity between pistachio and other nuts including cashew, almond, and peanut. Inhibition Western blot and inhibition ELISA studies were conducted to assess the presence of allergenic cross-reactivity between pistachio and the other tree nuts. Our results revealed that the prevalence of pistachio allergy is twice as much in pistachio cultivation regions than other areas. Western blotting and inhibition ELISA presented high percentages of inhibition with pistachio and cashew, followed by almond and, to some degree, peanut which indicates different levels of allergenic cross-reactivity. The results indicate that exposure of people to pistachio significantly affects the prevalence of its allergic reactions. In addition, it was observed that, among pistachio allergic subjects, such exposure may affect the co-sensitivities with other nuts, including cashew and almond. The plant taxonomic classification of pistachio and other tree nuts does appear to predict allergenic cross-reactivity.

1 January 2014 in Pharmacognosy Magazine
Verified
Journal Article
Open access
PDF file
JFJabbari Azad Farahzad
Jabbari Azad Farahzad
SSSaeed Samarghandian
Saeed Samarghandian
MSMohammad Ebrahim Shoshtari
Mohammad Ebrahim Shoshtari
JSJavad Sargolzaei
Javad Sargolzaei
HHHosna Hossinimoghadam
Hosna Hossinimoghadam
Objective: Safranal (2,6,6-trimethyl-1,3-cyclohexadiene-1-carboxaldehyde, C10H14O) is an active ingredient in the saffron, which is used in traditional medicine, and also, the biological activity of saffron in anti-cancer is in development. It has been reported to have anti-oxidant effects, but its anti-tumor effects remain uncertain. The aim of this study was to evaluate effects of safranal on anti-tumor on neuroblastoma cells. Materials and Methods: Neuroblastoma cells were cultured and exposed to safranal (0, 10, 15, 20, 50 μg/ml). Cell proliferation was examined using the 3-(4, 5-dimethyl thiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay. Apoptotic cells, cell cycle distribution, and sub-G1 fraction were analyzed using flow cytometric analysis after propidium iodide staining. Results: Safranal inhibited the growth of malignant cells in a dose-and time-dependent manner. The IC (50) values against the neuroblastoma cell line were determined as 11.1 and 23.3 μg/ml after 24 and 48 h, respectively. Safranal induced a sub-G1 peak in the flow cytometry histogram of treated cells compared to control cells indicating that apoptotic cell death is involved in safranal toxicity. Conclusions: Our pre-clinical study demonstrated a neuroblastoma cell line to be highly sensitive to safranal-mediated growth inhibition and apoptotic cell death. Although the molecular mechanisms of safranal action are not yet clearly understood, it appears to have potential as a therapeutic agent.

18 March 2010 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
MAMohammad-Ali Assarehzadegan
Mohammad-Ali Assarehzadegan
MSMojtaba Sankian
Mojtaba Sankian
FJFarahzad Jabbari
Farahzad Jabbari
MTMohsen Tehrani
Mohsen Tehrani
RFReza Falak
Reza Falak
AVAbdolReza Varasteh
AbdolReza Varasteh

1 September 2021 in Clinical Phytoscience
Verified
Journal Article
Open access
PDF file
NKNegar Khalighi
Negar Khalighi
FJFarahzad Jabbari-Azad
Farahzad Jabbari-Azad
MBMaral Barzegar-Amini
Maral Barzegar-Amini
JTJalil Tavakkol-Afshari
Jalil Tavakkol-Afshari
PLPouran Layegh
Pouran Layegh
RSRoshanak Salari
Roshanak Salari
Background: Althaea Officinalis introduced as an emerging anti-inflammatory agent with immunomodulatory effects that may suppress the symptoms of atopic eczema. In this study, we aimed to investigate the impact of liposomal formulation of Althaea Officinalis flower extract compared with steroids for atopic eczema treatment. Methods: In this randomized, double-blind controlled trial phase II, forty patients with moderate to severe allergic atopic eczema confirmed by skin prick test were enrolled in the study from October 2018 to January 2019. Steroids on the lesions of the left side of the body and topical Althaea Officinalis extract (intervention) or eucerin as a topical placebo on the lesions of the right side of the body were tested. SCORAD (SCORing Atopic Dermatitis) was assessed at the baseline, and two, and four weeks after completing the trial. Data were analyzed by SPSS version 22. Results: In the active treatment group, after two weeks, the SCORAD was significantly lower in the left side (recovery with steroid treatment) (p < 0.001), and after 4 weeks the SCORAD was lower on both sides, and there were no significant differences between two sides (similarity between Althaea Officinalis and steroid effects). In the control group, the SCORAD score was significantly lower on the left side (steroid) after two and four weeks (p < 0.001). There was no side effect and reaction to drugs. Conclusions: Considering the potential side effects of steroids, and the similar efficacy of Althaea Officinalis flower extract, using this component may be accompanied by higher benefits in patients with atopic eczema. Trial registration: IRCT2016102323235N5.

1 January 2019 in Journal of Research in Medical Sciences
Verified
Journal Article
Open access
PDF file
SDSajad Dehnavi
Sajad Dehnavi
FAFarahzad Jabbari Azad
Farahzad Jabbari Azad
RHReza Farid Hoseini
Reza Farid Hoseini
NMNasrin Moazzen
Nasrin Moazzen
JTJalil Tavakkol-Afshari
Jalil Tavakkol-Afshari
MMMojgan Mohammadi
Mojgan Mohammadi
Background: Allergic Rhinitis (AR) is the most common allergic disease worldwide. The present study, evaluated effects of synbiotic on gene expression of interferon-gamma (IFN-γ), interleukin-4 (IL-4), interleukin-10 (IL-10), interleukin-17 (IL-17), transforming growth factor beta (TGF-β), and forkhead box P3 (FoxP3) in AR patients who received concomitant immunotherapy in a placebo-controlled clinical trial. Materials and Methods: Twenty AR patients were randomized in synbiotic and placebo groups and received cluster immunotherapy for 2 months. RNA was extracted from peripheral PBMCs, then the cDNA synthesized. Subsequently, SYBR Green real-time Reverse transcription polymerase chain reaction technique was employed for studying the expression of mentioned genes. In addition, SNOT-22 and mini-Rhinoconjunctivitis Quality of Life Questionnaire questionnaires were completed by patients. Data were analyzed before and also 2 and 6 months after intervention. Results: Clinical symptoms and quality of life were improved with immunotherapy, but there was no significant difference between the placebo and synbiotic groups. Gene expression of IFN-γ, TGF-β, and FoxP3 was increased whereas the gene expression of IL-4 and IL-10 decreased, but not significant. Interestingly, the gene expression of IL-17 in the synbiotic group was significantly decreased versus placebo after 2 months (P = 0.001) and also at the end of intervention (P = 0.0001) comparing with the time zero. Conclusion: Significant reduction in the IL-17 gene expression following administration of synbiotic versus placebo shows the importance of synbiotic in control of the immunopathogenesis of AR. Further studies with more samples are recommended. In addition, evaluating the effects of synbiotic in patients who do not undergo immunotherapy is suggested to get a better conclusion.

1 October 2016
Verified
Journal Article
Closed access
NANazila Ariaee
Nazila Ariaee
RFReza Farid
Reza Farid
FSFahimeh Shabestari
Fahimeh Shabestari
MSMohamad Shabestari
Mohamad Shabestari
FAFarahzad Jabbari Azad
Farahzad Jabbari Azad